tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate

C23H30N2O5 — CID 53359319

IUPACtert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
SMILESC#CCO[C@@H]1C(=O)N(Cc2ccccc2)[C@@H]1[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C
InChIInChI=1S/C23H30N2O5/c1-7-13-28-19-18(24(20(19)26)14-16-11-9-8-10-12-16)17-15-29-23(5,6)25(17)21(27)30-22(2,3)4/h1,8-12,17-19H,13-15H2,2-6H3/t17-,18+,19-/m0/s1
InChIKeyPAHAEJONGWVYQI-OTWHNJEPSA-N
MW414.50 g/mol
LogP2.79
Rot. Bonds5

About tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate

tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate (PubChem CID 53359319) has the molecular formula C23H30N2O5 and a molecular weight of 414.50 g/mol. Its IUPAC name is tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate.

Molecular Properties

Compound Nametert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
PubChem CID53359319
Molecular FormulaC23H30N2O5
Molecular Weight414.50 g/mol
Exact Mass414.22
IUPAC Nametert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
SMILESC#CCO[C@@H]1C(=O)N(Cc2ccccc2)[C@@H]1[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C
InChIInChI=1S/C23H30N2O5/c1-7-13-28-19-18(24(20(19)26)14-16-11-9-8-10-12-16)17-15-29-23(5,6)25(17)21(27)30-22(2,3)4/h1,8-12,17-19H,13-15H2,2-6H3/t17-,18+,19-/m0/s1
InChIKeyPAHAEJONGWVYQI-OTWHNJEPSA-N
XLogP2.79
TPSA68.31 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500414.50
LogP ≤ 52.79
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate?
The IUPAC name of tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate (CID 53359319) is tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate.
What is the SMILES notation for tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate?
The canonical SMILES for tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate is C#CCO[C@@H]1C(=O)N(Cc2ccccc2)[C@@H]1[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C.
What is the InChIKey of tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate?
The InChIKey is PAHAEJONGWVYQI-OTWHNJEPSA-N. The full InChI is InChI=1S/C23H30N2O5/c1-7-13-28-19-18(24(20(19)26)14-16-11-9-8-10-12-16)17-15-29-23(5,6)25(17)21(27)30-22(2,3)4/h1,8-12,17-19H,13-15H2,2-6H3/t17-,18+,19-/m0/s1.
What are the key properties of tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate?
tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate has a molecular weight of 414.50 g/mol, XLogP of 2.79, 5 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl (4R)-4-[(2R,3S)-1-benzyl-4-oxo-3-prop-2-ynoxyazetidin-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate is sourced from PubChem (CID 53359319), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).